![]() |
Link a Tocris |
![]() |
Información esencial Tocris |
![]() |
Posters y Guias Tocris |
![]() |
Infromación Gnral Reactivos |
Empresa de biotecnología con sede en Houston, cerca del Centro Médico de Texas, centrada en I+D, fabricación y comercialización de Proteínas, Anticuerpos y Kits de Inmunoensayo de altísima calidad.
ACS3; BPES2; BPES3; SCS; Class A basic helix-loop-helix protein 38; Acrocephalosyndactyly 3; Saethre-Chotzen Syndrome; Blepharophimosis,Epicanthus Inversus And Ptosis 3
BTKL; PSCTK5; PTK4; RLK; TKL; PTK4 Protein Tyrosine Kinase 4; Resting lymphocyte kinase
BTKL; PSCTK5; PTK4; RLK; TKL; PTK4 Protein Tyrosine Kinase 4; Resting lymphocyte kinase
DAP12; KARAP; PLOSL; Killer Activating Receptor Associated Protein; DNAX-Activation Protein 12
DAP12; KARAP; PLOSL; Killer Activating Receptor Associated Protein; DNAX-Activation Protein 12
OCAIA; OCA1A; OCA1; CMM8; Oculocutaneous Albinism IA; Monophenol monooxygenase; Tumor rejection antigen AB
OCAIA; OCA1A; OCA1; CMM8; Oculocutaneous Albinism IA; Monophenol monooxygenase; Tumor rejection antigen AB
OCAIA; OCA1A; OCA1; CMM8; Oculocutaneous Albinism IA; Monophenol monooxygenase; Tumor rejection antigen AB
OCAIA; OCA1A; OCA1; CMM8; Oculocutaneous Albinism IA; Monophenol monooxygenase; Tumor rejection antigen AB
OCAIA; OCA1A; OCA1; CMM8; Oculocutaneous Albinism IA; Monophenol monooxygenase; Tumor rejection antigen AB